Compounds of unstable dipeptidyl peptidase iv inhibitors

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 5/083 (2006.01) A61K 38/06 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2335978

The invention relates to compounds of unstable inhibitors of dipeptidyl peptidase IV (DP IV) which comprise general formula A-B-C, whereby A represents an amino acid, B represents the chemical bond between A and C or an amino acid, and C represents an unstable inhibitor of DP IV. Such compounds are used for treating altered glucose tolerance, glucosuria, hyperlipidemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy, nephropathy, and secondary diseases in mammals caused by diabetes mellitus.

L'invention concerne des composés d'inhibiteurs instables de la dipeptidylpeptidase IV (DP IV), qui présentent la formule générale A-B-C, dans laquelle A est un aminoacide, B est la liaison chimique entre A et C ou un aminoacide, et C est un inhibiteur instable de la DP IV. Ces composés s'utilisent pour traiter la tolérance glucidique altérée, la glucosurie, l'hyperlipidémie, les acidoses métaboliques, le diabète sucré, la neuropathie et la néphropathie diabétiques, ainsi que les maladies provoquées par le diabète sucré chez les mammifères.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compounds of unstable dipeptidyl peptidase iv inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds of unstable dipeptidyl peptidase iv inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds of unstable dipeptidyl peptidase iv inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2066731

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.